TIAA Trust National Association decreased its position in Constellation Brands, Inc. (NYSE:STZ - Free Report) by 96.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,575 shares of the company's stock after selling 69,156 shares during the period. TIAA Trust National Association's holdings in Constellation Brands were worth $569,000 at the end of the most recent quarter.
A number of other large investors also recently bought and sold shares of the business. Mainstream Capital Management LLC acquired a new stake in shares of Constellation Brands in the fourth quarter valued at approximately $25,000. SBI Securities Co. Ltd. acquired a new stake in shares of Constellation Brands in the fourth quarter valued at $26,000. Compagnie Lombard Odier SCmA acquired a new position in shares of Constellation Brands during the fourth quarter worth about $27,000. Union Bancaire Privee UBP SA acquired a new position in Constellation Brands during the 4th quarter worth approximately $28,000. Finally, Versant Capital Management Inc raised its stake in Constellation Brands by 887.5% in the fourth quarter. Versant Capital Management Inc now owns 158 shares of the company's stock valued at $35,000 after buying an additional 142 shares in the last quarter. Institutional investors and hedge funds own 77.34% of the company's stock.
Constellation Brands Stock Performance
Shares of STZ traded up $0.53 during mid-day trading on Monday, reaching $184.27. The company's stock had a trading volume of 661,439 shares, compared to its average volume of 1,624,382. Constellation Brands, Inc. has a 1-year low of $160.46 and a 1-year high of $274.87. The stock has a market cap of $33.30 billion, a P/E ratio of 49.59, a PEG ratio of 1.52 and a beta of 1.75. The business has a 50-day simple moving average of $177.19 and a two-hundred day simple moving average of $214.50. The company has a current ratio of 1.10, a quick ratio of 0.46 and a debt-to-equity ratio of 1.26.
Constellation Brands (NYSE:STZ - Get Free Report) last released its earnings results on Friday, January 10th. The company reported $3.25 EPS for the quarter, missing the consensus estimate of $3.33 by ($0.08). The firm had revenue of $2.46 billion during the quarter, compared to the consensus estimate of $2.53 billion. Constellation Brands had a net margin of 6.27% and a return on equity of 26.55%. Constellation Brands's quarterly revenue was down .3% compared to the same quarter last year. During the same period in the prior year, the business earned $3.19 earnings per share. As a group, equities research analysts anticipate that Constellation Brands, Inc. will post 13.5 earnings per share for the current fiscal year.
Constellation Brands Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, February 21st. Stockholders of record on Friday, February 7th were given a dividend of $1.01 per share. This represents a $4.04 annualized dividend and a dividend yield of 2.19%. The ex-dividend date of this dividend was Friday, February 7th. Constellation Brands's dividend payout ratio (DPR) is 108.60%.
Insiders Place Their Bets
In other Constellation Brands news, Director William T. Giles bought 1,000 shares of Constellation Brands stock in a transaction dated Friday, January 17th. The stock was purchased at an average price of $186.39 per share, for a total transaction of $186,390.00. Following the completion of the purchase, the director now directly owns 1,463 shares of the company's stock, valued at approximately $272,688.57. This trade represents a 215.98 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 12.19% of the company's stock.
Analyst Ratings Changes
Several equities research analysts have recently weighed in on STZ shares. Jefferies Financial Group reissued a "hold" rating and issued a $201.00 price objective (down from $310.00) on shares of Constellation Brands in a report on Monday, January 13th. Royal Bank of Canada reduced their price target on Constellation Brands from $293.00 to $289.00 and set an "outperform" rating for the company in a report on Friday, March 7th. Roth Capital dropped their target price on shares of Constellation Brands from $298.00 to $284.00 and set a "buy" rating for the company in a report on Friday, January 17th. Barclays decreased their price objective on shares of Constellation Brands from $205.00 to $203.00 and set an "overweight" rating on the stock in a research report on Thursday. Finally, Piper Sandler cut Constellation Brands from an "overweight" rating to a "neutral" rating and lowered their target price for the company from $245.00 to $200.00 in a report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating and eleven have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $249.18.
Read Our Latest Stock Analysis on STZ
Constellation Brands Profile
(
Free Report)
Constellation Brands, Inc, together with its subsidiaries, produces, imports, markets, and sells beer, wine, and spirits in the United States, Canada, Mexico, New Zealand, and Italy. The company provides beer primarily under the Corona Extra, Corona Familiar, Corona Hard Seltzer, Corona Light, Corona Non-Alcoholic, Corona Premier, Corona Refresca, Modelo Especial, Modelo Chelada, Modelo Negra, Modelo Oro, Victoria, Vicky Chamoy, and Pacifico brands.
Read More

Before you consider Constellation Brands, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Constellation Brands wasn't on the list.
While Constellation Brands currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.